Effective Treatment for Fluid Overload

Aquadex FlexFlow® System

Customer Support
1-855-786-2778

Aquapharesis Diagram_600x900 no CHF-01Aquapheresis therapy, delivered by the Aquadex FlexFlow system, uses a simplified approach to ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. Compared to renal replacement devices used for ultrafiltration, the Aquadex FlexFlow system is smaller and more portable.

Physicians can specify and adjust the exact amount and rate of fluid to be removed from each patient, resulting in a gradual reduction that has been shown to have no significant clinical impact on blood pressure, heart rate, or the balance of electrolytes (e.g. sodium, potassium, etc.) in the body.

Up to 500 ml or 1.1 lb of fluid can be safely removed per hour. The average removal rate is 250 ml or ½ lb an hour and treatment usually lasts about 24 hours.¹ 


Aquadex FlexFlow Technology

AQS-Hero_imageThe Aquadex FlexFlow is designed to simply, safely, and precisely remove excess fluid (primarily excess salt and water) from patients suffering from fluid overload who have failed diuretic therapy. With the Aquadex FlexFlow, medical practitioners can specify and control the amount of fluid to be extracted at a safe, predictable, and effective rate. The Aquadex FlexFlow has been shown to have no clinically significant impact on electrolyte balance, blood pressure or heart rate.²

Easy to Operate, Safe to Use

The Aquadex FlexFlow offers a precise and safe approach to treating fluid overload:

  • Allows a medical practitioner to specify the amount of fluid to be removed from each individual patient
  • Aquapheresis therapy can be performed via peripheral or central venous access
  • Console provides highly automated operation with only one setting required to begin
  • Utilizes a single-use, disposable auto-loading blood filter circuit that facilitates easy set-up
  • Console guides medical practitioner through the setup and operational process

Rx Only

Indication: The Aquadex FlexFlow® System is indicated for temporary (up to 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy; and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies.

References
¹SAFE Trial: Jaski BE, et al. J Card Fail. 2003 Jun; 9(3): 227-231; UNLOAD Trial: Costanzo MR, et al. J Am Coll Cardiol. 2007 Feb 13; 49(6): 675-683.
²SAFE Trial: Jaski BE, et al. J Card Fail. 2003 Jun; 9(3): 227-231; RAPID Trial: Bart BA, et al. J Am Coll  Cardiol. 2005 Dec 6; 46(11): 2043-2046.